Gabelli & Co Investment Advisers’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-212,054	Closed	-$7.99M	–	552
2021 Q1	$7.99M	Buy	+212,054	New	+$5.29M	0.99%	24

Gabelli & Co Investment Advisers's FPRX Position: Q2 2021 in Review

Gabelli & Co Investment Advisers sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 212,054 shares — an estimated $7.99M sold.

Gabelli & Co Investment Advisers first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $7.99M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Gabelli & Co Investment Advisers reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 212,054 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $7.99M.
Gabelli & Co Investment Advisers first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Five Prime Therapeutics, Inc. position peaked at $7.99M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.